This growth is largely attributed to the rising prevalence of chronic disease conditions and the associated demand for vaccines, biologics, and precision medicine, the market for which is estimated to reach USD 157.1 billion by 2032
(See the articles below)
From the perspective of the clinical care of T2D patients who require intensified injection therapy, our findings are consistent with existing treatment guidelines [1, 3] and a real-world study [47], showing that using a GLP-1RA versus insulin therapy has therapeutic benefits in terms of reduced risks of hypoglycemia and all-cause death
Look for options that include balancing ingredients like Niacinamide or green tea, and skip anything that feels greasy
Although promising, these applications are still under study, and they should only be used as prescribed by a healthcare professional
Neuroscience Letters, 13 (1), 5560